Business Context and Reporting Period
This Form 8-K was filed by BioRestorative Therapies, Inc. on May 27, 2015, reporting events occurring between May 20, 2015, and May 27, 2015. The filing details material definitive agreements and unregistered sales of equity securities involving debt-to-equity conversions and warrant issuances.
Key Financial Metrics and Transactions
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or margins. Instead, it reports specific capital structure changes:
- Debt Conversion (Westbury): Converted $4,480,374 in principal and accrued interest into 14,934,578 shares of common stock and a warrant for 3,733,645 shares.
- Debt Conversion (Other Lenders): Converted $336,301 in indebtedness into 1,135,277 shares of common stock and warrants for 258,334 shares.
- Loan Financing: Received a $50,000 loan in exchange for a warrant to purchase 58,929 shares.
- Service Compensation: Issued 30,000 shares valued at approximately $7,000 for services rendered.
Material Changes Versus Prior Period
The most significant change is the shift in ownership control. Following the exchange with Westbury (Bermuda) Ltd., Westbury beneficially owns 23,833,223 shares, representing 39.7% of the Company's outstanding common stock. This transaction triggered a reportable change in control under Item 5.01. Additionally, the Company reduced its outstanding debt by approximately $4.8 million through equity issuance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risks and contingencies identified are:
- Dilution: Significant issuance of shares and warrants may dilute existing shareholders.
- Warrant Expiration Extension: As part of the Westbury agreement, the expiration of an existing warrant for 800,000 shares was extended from December 31, 2015, to December 31, 2017.
- Regulatory Compliance: All issuances relied on exemptions under Section 4(a)(2), Section 3(a)(9) of the Securities Act, or Regulation S, assuming investors were accredited and had access to company information.
Investor Verification Checklist
- Verify the updated total share count and the exact percentage ownership of Westbury (Bermuda) Ltd. post-transaction.
- Confirm the total reduction in outstanding debt obligations following the $4.8 million conversion.
- Review the terms of the newly issued warrants, specifically the exercise prices ($0.75 and $0.50) and expiration dates.
- Assess the impact of the 39.7% ownership stake held by Westbury on future corporate governance and decision-making.